Business Context and Reporting Period
Company: Xtant Medical Holdings, Inc. (XTNT)
Filing Type: Form 8-K (Current Report)
Date of Report: August 11, 2026
Reporting Period: Second Quarter of 2026
This filing announces the financial results for the second quarter of 2026. The full details of the results are contained in a press release furnished as Exhibit 99.1, which is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Key Financial Metrics
The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are referenced as being located in the press release (Exhibit 99.1) but are not included in the body of this 8-K document.
Non-GAAP Measures Discussed:
- Adjusted EBITDA: The Company utilizes non-GAAP adjusted EBITDA to assess core operational performance.
- Reconciliation: The press release reconciles Adjusted EBITDA to Net Income (Loss), the most directly comparable GAAP measure.
Material Changes and Adjustments
The filing details specific items excluded from the calculation of non-GAAP adjusted EBITDA to facilitate period-over-period comparability and reflect ongoing operating results. These exclusions include:
- Non-cash compensation: Equity awards based on future market valuations.
- Unrealized foreign currency translation gains or losses.
- Write-off of distribution agreement deposit.
- Divestiture/acquisition-related expenses and income: Including legal fees, accounting fees, and transition services agreement income.
- Acquisition-related fair value adjustments.
- Separation-related expenses.
The filing does not provide specific quantitative comparisons to the prior comparable period.
Guidance, Outlook, and Risks
Management Commentary: Management states that non-GAAP adjusted EBITDA is used for internal decision-making regarding resource allocation for sales, marketing, and R&D. It is believed to provide meaningful supplemental information by factoring out charges not related to regular, ongoing business.
Risks and Limitations:
- Non-GAAP measures are not in accordance with GAAP and may differ from measures used by other companies.
- These measures do not reflect all amounts associated with financial results as determined under GAAP.
- Investors are cautioned to use non-GAAP information in conjunction with corresponding GAAP measures.
The filing does not contain specific forward-looking guidance, outlook figures, or details on unusual items beyond the standard exclusions listed above.
Investor Verification Checklist
- Verify Numerical Results: Review Exhibit 99.1 (Press Release) for actual Q2 2026 revenue, net income, and cash flow figures, as they are absent from this 8-K text.
- Review Reconciliation Tables: Examine the reconciliation of Net Income to Adjusted EBITDA in the press release to understand the magnitude of excluded items.
- Assess Exclusions: Evaluate the specific dollar amounts of non-cash compensation, foreign currency impacts, and acquisition-related costs to determine their impact on GAAP profitability.
- Check for Forward Guidance: Confirm if the press release contains updated full-year 2026 guidance or outlook statements.